Don't get sucked in by pie in the sky.
New technologies sound exciting - the early companies usually fall by the wayside.
TRXC is at a $50M annual burn rate. A dilutive offering has already been filed.
The market cap is $200M.
Medical device companies sell for 20X earnings.
So IF sometime in the future, they get a product approved and produce $10M of earnings,
you'll be able to buy the stock at half the current price because there will be twice as many shares
I would wait this one out.